1. Home
  2. BWXT vs RGEN Comparison

BWXT vs RGEN Comparison

Compare BWXT & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BWX Technologies Inc.

BWXT

BWX Technologies Inc.

HOLD

Current Price

$177.18

Market Cap

15.4B

Sector

N/A

ML Signal

HOLD

Logo Repligen Corporation

RGEN

Repligen Corporation

HOLD

Current Price

$164.88

Market Cap

8.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BWXT
RGEN
Founded
1867
1981
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
15.4B
8.2B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
BWXT
RGEN
Price
$177.18
$164.88
Analyst Decision
Buy
Buy
Analyst Count
9
10
Target Price
$194.66
$174.90
AVG Volume (30 Days)
998.6K
663.3K
Earning Date
11-03-2025
10-28-2025
Dividend Yield
0.56%
N/A
EPS Growth
10.60
N/A
EPS
3.34
0.03
Revenue
$3,058,850,000.00
$707,890,000.00
Revenue This Year
$18.91
$17.84
Revenue Next Year
$16.08
$12.44
P/E Ratio
$53.18
$6,537.77
Revenue Growth
14.01
11.74
52 Week Low
$84.21
$102.97
52 Week High
$218.50
$182.52

Technical Indicators

Market Signals
Indicator
BWXT
RGEN
Relative Strength Index (RSI) 47.97 56.56
Support Level $167.03 $156.01
Resistance Level $181.01 $167.74
Average True Range (ATR) 5.61 4.38
MACD 0.83 -0.10
Stochastic Oscillator 60.04 75.62

Price Performance

Historical Comparison
BWXT
RGEN

About BWXT BWX Technologies Inc.

BWX Technologies Inc is a specialty manufacturer and service provider of nuclear components, operating in two segments: Government Operations and Commercial Operations. The Government Operations segment produces naval nuclear reactors and fuel for the U.S. Naval Nuclear Propulsion Program, while the Commercial Operations segment designs and manufactures commercial nuclear steam generators, heat exchangers, pressure vessels, reactor components, and other auxiliary equipment, including containers for the storage of spent nuclear fuel and other high-level nuclear waste. The majority of the company's revenue comes from Government Operations, with sales principally in the United States, Canada, and other regions.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: